Several preclinical studies have revealed that the effect of cancer vaccines was able to enhance by combination with more immunomodulators, such as IL‐2, GM‐CSF, IL‐15, IL‐7, or IFN, and so on 9. The gene discussed is CSF2; the disease is cancer.